Cite
HARVARD Citation
Vitale, M. et al. (n.d.). 891PCorrelation between immuno-related adverse events (IRAEs) occurrence and clinical outcome in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: IRAENE trial, an Italian multi-institutional retrospective study. Annals of oncology. p. . [Online].